Edition:
United States

People: Depomed Inc (DEPO.O)

DEPO.O on Nasdaq

18.48USD
18 Jan 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$18.48
Open
$18.43
Day's High
$18.77
Day's Low
$18.12
Volume
791,191
Avg. Vol
1,809,784
52-wk High
$27.02
52-wk Low
$12.25

Moretti, August 

Mr. August J. Moretti is Chief Financial Officer and Senior Vice President of Depomed Inc., since January 2012. From 2004 to December 2011, Mr. Moretti served as Chief Financial Officer and Senior Vice President of Alexza Pharmaceuticals, Inc., a publicly-held pharmaceutical company. From 2001 to 2004, Mr. Moretti served as Chief Financial Officer of Alavita, Inc. (formerly Surromed, Inc.), a privately-held biotechnology company. Prior to Alavita, Mr. Moretti was a partner of Heller Ehrman LLP, an international law firm. Mr. Moretti holds a B.A. in economics from Princeton University and a J.D. from Harvard Law School.

Basic Compensation

Total Annual Compensation, USD 612,235
Restricted Stock Awards, USD 489,570
Long-Term Incentive Plans, USD --
All Other, USD 388,734
Fiscal Year Total, USD 1,490,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 5,000 68,900.00
Name Fiscal Year Total

Peter Staple

329,958

James Schoeneck

6,329,920

August Moretti

1,490,540

Matthew Gosling

2,022,450

Srinivas Rao

967,260

Thadd Vargas

1,323,430
As Of  30 Dec 2015